Coordinator: Enrique de Álava/ Co-coordinator: Ignacio Melero
The determination of biomarkers in a tumour tissue and in peripheral blood is vital information, capable of predicting the probability of response of cancer patients to different treatments such as the ones based on directed or immunological therapies. Due to its lower incidence in society we currently have less knowledge of this type of biomarkers in low prevalence tumours.
This programme has combined the potential of 7 research groups expert in low prevalence tumours, including carcinomas, sarcomas, melanomas and tumours of the nervous system, to identify and validate new biomarkers of tissues connected with systemic disease and metastatic dissemination, the tumour microenvironment (especially inflammatory and immune components) and possible therapeutic targets for this type of neoplasm.
Main researcher | Consortium Institutions | Regions |
---|---|---|
Enrique de Álava | Hospital Virgen del Rocío-IBiS | Andalucía |
Ignacio Melero | Clínica Universidad de Navarra | Navarra |
Xavier Matías-Guíu | Instituto de Investigación Biomédica de Lleida | Cataluña |
Rafael López López | Complejo Hospitalario Universitario de Santiago | Galicia |
Santiago Ramón Y Cajal | Intituto de Investigación Vall d'Hebron | Cataluña |
Francesc X. Bosch | Hospital Universitario de Bellvitge | Cataluña |
Rosa Noguera | Instituto de Investigación Sanitaria INCLIVA | Valencia |